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ABSTRACT 
The effects of Mycoplasma bovis on activation and cytotoxicity of bovine aortic and 
pulmonary microvascular endothelial cells were studied. Inoculation of bovine endothelial 
cells with M. bovis in vitro induced mediators such as vascular cellular adhesion molecule- I 
and monocyte chemoattractant protein- I, which are specific for mononuclear cell but not for 
neutrophil extravasation. Differential activation of endothelial cells was also observed, with 
early activation of proinflammatory cytokines interlukin-1~ (IL-1 ~) and IL-6 in 
microvascular endothelial cells, while induction of monocyte chemoattractant protein-I and 
IL-8 was limited to microvascular endothelial cells. We also found that there were significant 
strain differences between responses to abscess-forming strain M. bovis 428E and 
nonabscess-forming strain DSA16. Specifically, only DSA16 was subcytotoxic to both 
endothelial cell types. As for their activation effects, significant strain differences were 
limited to responses in microvascular cells. Strain DSA 16 induced significantly higher levels 
of mediators compared to strain 428E. Taken together, these results are consistent with the 
predominant perivascular mononuclear cell infiltration observed in M. bovis-infected lung 
lesions. 
1 
CHAPTERl.GENERALINTRODUCTION 
Introduction to mycoplasmas 
Mycoplasmas belong to the class Mollicutes (mollis, soft; cutis, skin) and are 
distinguished from other prokaryotes by the lack of a cell wall, small size, and minute 
genomes (1). Over 190 species have been identified and most are parasites with strict host 
specificity. Affected hosts include mammals, birds, reptiles, fish, and plants (2). Although 
some of mycoplasmas are commensal, others can cause acute and chronic diseases or are 
implicated as cofactors in diseases (1). 
The subject of this study, Mycoplasma bovis , is a highly adapted bovine pathogen 
causing a variety of diseases, including pneumonia, mastitis, arthritis, and otitis media (3). 
Unlike most mycoplasmas considered as surface parasites and causing localized chronic 
infections, M. bovis is highly invasive and systemic infections have been demonstrated in 
mastitis and arthritis through hematogenous dissemination ( 4, 5). Typical lung and joint 
lesions are characterized by localized perivascular necrotic lesions with the infiltrations of 
neutrophils, macrophages and lymphocytes (6). In addition, localized vasculitis in the lung 
as well as thrombosis of the subsynovial vessels in joints have also been described (5, 7). 
The present research was undertaken to better understand the direct interactions between M. 
bovis and bovine primary vascular endothelial cells. 
It was found that M. bovis induced differential activation of bovine aortic and 
pulmonary microvascular cells, with the induction of mediators specific for mononuclear cell 
transmigration. Strain differences were also found in that only a nonabscessing strain was 
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cytotoxic to endothelial cells and induced higher expression of cytokines and chemokines in 
microvascular endothelial cells. 
Thesis Organization 
This thesis is composed of a literature review and one manuscript. The literature 
review includes two sections: 1) a general overview of M. bovis diseases and pathogenicity, 
2) an introduction to endothelial cells emphasizing their role in inflammatory responses, 
followed by studies of mycoplasma effects on endothelial cells. The main portion of this 
thesis contains one manuscript (chapter 3), Differential gene expression and cytotoxicity of 
bovine aortic and pulmonary microvascular endothelial cells infected with Mycoplasma 
bovis, which will be submitted to Microbial Pathogenesis for publication. The last part is a 
brief summary section discussing the implications of the present work and possible directions 
for future studies. 
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CHAPTER 2. LITERATURE REVIEW 
1. Mycoplasma bovis and pathogenicity 
1.1 Overview of diseases 
M. bovis, initially designated as Mycoplasma agalactiae subsp. bovis due to a wide-
ranging analogy to M. agalactiae, was first isolated from a case of severe bovine mastitis in 
1961 in the USA (8). It was given its present name in 1976 (9). Among more than 20 
mycoplasma species colonizing the bovine, M. bovis is well established as one of the most 
pathogenic bovine mycoplasma species (3). Infections caused by M. bovis occur all over the 
world. The presence of M. bovis is often overlooked because of the accompanying role of 
other bovine pathogens as well as the absence of routine monitoring for mycoplasmas (10). A 
variety of diseases caused by M. bovis have been reported, including mastitis, pneumonia, 
arthritis, genital disorders, skin abscesses, conjunctivitis, otitis media, and meningitis (3, 11-
17). 
M. bovis is a highly restricted bovine pathogen. This is partly attributed to its limited 
biosynthetic capabilities because of its limited genomic size (18, 19). The genomic size of M. 
bovis is 1100 kbp, which is only about 1/4 of Escherichia coli (2, 19). However, M. bovis can 
be occasionally isolated from buffalo, small ruminants, and even a human (10, 20). 
Pneumonia in goats and mastitis in sheep have been demonstrated by inoculation of this 
organism into respiratory tract or into the mammary glands, respectively (21, 22). 
Experimental inoculation of piglets failed to cause any signs of infection or colonization (3). 
However, experimentally infected mice showed severe pathological and histopathologic 
changes in the mammary glands (23) . 
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Many cattle herds become infected by the introduction of clinically healthy calves 
that are shedding the organism (3). The upper respiratory tract and genital tract are 
considered as the natural reservoirs of M. bovis (24). Cattle become infected via respiratory 
tract, genital tract, or by the ingestion of M. bovis-infected milk (24). 
Laboratory diagnosis is necessary because clinical and pathological signs are not 
characteristic for M. bovis infections (10). Many samples have been used for the diagnosis of 
M. bovis including nasal swabs, bronchial alveolar lavage, lung tissues, milk, joint fluid, eye 
swabs, semen or genital discharge, and serum (10). Culture methods are highly specific and 
sensitive but rather time-consuming (3). Antibodies in blood or milk samples can be detected 
by indirect hemagglutination and ELISA (3). The ELISA test is highly sensitive and less 
time-consuming than culture methods. It could be used for cattle herd diagnosis and regular 
screening. The limitations with serological diagnosis are that antibody is undetectable during 
the incubation period and is insufficient to detect shedders (3). Monoclonal antibodies have 
been used to detect M. bovis by antigen capture ELISA (25, 26). DNA-based diagnostic 
methods have also been developed (27-29). 
M. bovis infection causes considerable economic losses in intensive dairy and beef 
operations because of the need to cull mastitic cows to prevent dissemination, or due to 
mortality and weight losses (3). This is partly attributed to the poor responsiveness of M. 
bovis to antibiotic treatments. M. bovis is intrinsically resistant to some antibiotics such as 
penicillin because it lacks a cell wall (30). It is susceptible to some antibiotics including 
enrofloxacin, tylosin, lincomycin, spectinomycon, and oxytetracycline in vitro (31). 
Treatment is often considered undesirable, since the infection can not be eliminated, even 
though those antibiotics may reduce secondary infections (10). 
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It is highly desirable to use vaccines to control and prevent M. bovis diseases given 
the poor responsiveness to antibiotic treatments. However, there are few vaccines currently 
available. Although some experimental vaccines demonstrated some protection or reduced 
losses, other vaccines against systemic diseases of M. bovis such as arthritis and mastitis have 
been less successful and sometimes were reported to make the condition worse (10, 32-35). 
1.2 Systemic phases of diseases 
Although most mycoplasmas are considered surface parasites and only cause 
localized, chronic infections, M. bovis is considered a highly invasive bovine pathogen (36, 
37). It is capable of translocation across respiratory epithelium and systemically spread 
through the bloodstream (38-40). Hematogenous spread of M. bovis was demonstrated by the 
isolation of the organism from blood after intratracheal inoculation into gnotobiotic calves 
(13). Recovery of M. bovis or detection of antigens from liver and kidneys also suggests 
systemic infections (7, 41 ). It has also been reported that M. bovis mas ti tis and arthritis were 
caused by hematogenous dissemination of the organism (3, 5, 30). 
M. bovis pneumonia, as demonstrated in gnotobiotic calves, has been characterized by 
typical lung lesions which were described as "focal variably sized coagulative necrosis 
lesions located in peribronchiolar and perivascular areas, surrounded by mononuclear cells 
and suppurative bronchiolitis with varying degrees of peribronchiolar lymphoreticular 
hyperplasia" (6, 13). The lesions were recognized as a combination of the necrotic effects of 
M. bovis and host cellular responses with predominantly mononuclear cell infiltration (13). 
The granuloma-like response suggests that M. bovis was not only tissue invasive, but 
survived or was capable of avoiding early, predominantly phagocytic elements of 
inflammation and persisted to elicit more chronic cell-mediated immune response (42). 
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Activation of lung vascular endothelium would be a component of observed perivascular 
necrotic lesions infiltrated with neutrophils and macrophages as well as lymphocytes. 
Joint swelling and lameness are usually a result of M. bovis arthritis and tenosynovitis 
( 4 ). Thrombosis of the subsynovial vessels and aggregation of platelets have been reported in 
calves inoculated intraarticularly suggesting the interaction of M. bovis with the vasculature 
and coagulation processes of the host ( 4, 43). 
1.3 Heterogeneity among strains of M. bovis 
There is a considerable degree of heterogeneity among strains of M. bovis. For 
example, M. bovis can cause severe disease, or not cause any clinical symptoms (44). It was 
reported that there were 13 different genomic groups among 37 M. bovis strains tested by 
restriction endonuclease analysis. Antigenic profiles differed markedly among strains from 
different as well as from the same genomic groups ( 45). The adherence rate of M. bovis 
strains to bovine cell lines varied from 3.4% to 19.1 % (46). Heterogeneity among M. bovis 
strains with respect to abscess formation and cytotoxicity was also noted. In a study of M. 
bovis-positive fatal chronic pneumonia calves, 11 cases had lung abscesses while 13 cases 
did not show abscesses (6). Interestingly, M. bovis strains isolated from abscess-associated 
pneumonia cases were not cytotoxic to bovine lung fibroblast cells while non-abscess-
associated strains exhibited varied cytotoxic activity (47). AM. bovis abscess-forming strain 
(428E) and a nonabscess-forming strain (DSA16) were used in this project. 
1.4 Pathogenesis of M. bovis 
The virulence capabilities of M. bovis are complex and the molecular mechanisms of 
pathogenicity remain largely elusive. Strategies employed by M. bovis while interacting with 
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the host include adherence, invasion, and damage to host cells, as well as modulation and 
avoidance of host immune responses. 
1.4.1 Adherence to host cells 
Adherence to host cells is considered an initial step for colonization and infection 
(48). It is regarded as the major virulence factor in some mycoplasmas due to the loss of 
virulence in some non-adhering isolates or mutants ( 46). A specialized terminal tip organelle 
is involved in attachment to host cells by some flask-shaped mycoplasmas such as 
Mycoplasma pneumoniae and Mycoplasma genitalium (49, 50). However, there is no 
evidence of M. bovis possessing attachment organelles ( 46). 
There is a complex and multifactorial adherence interaction between M. bovis and 
host cells. Membrane proteins either variable or non-variable on M. bovis surface are 
presumed to mediate the attachment to host cells due to the lack of cell wall and a 
polysaccharide capsule (39, 51). A 32 kDa hydrophilic protein, designed as P26, was 
involved in the attachment of M. bovis to cultured embryonic bovine lung cells through sialic 
acid and sulfatide group receptors (52, 53). Three variable surface proteins (Vsps) 
participated in cytoadherence. Decreased attachment was reported when monoclonal 
antibody 1E5 directed against a common epitope of VspA and VspB was added to adherence 
assays (51, 53). Adherence to primary bovine bronchial epithelial cells was reduced by 
antibodies directed against VspC and VspF (54). However, different surface proteins 
mediated adherence to primary bovine bronchial epithelial cells and to embryonic bovine 
lung cells (54 ). It was also reported that low in-vitro passage strains adhered with higher 
avidity than high passage strains (54). The decreased adherence rate with high passage may 
explain why reduced mastitis lesions were obtained in mice inoculated with high passage M. 
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bovis as compared to those inoculated with low passage M. bovis (23). Although adherence 
rate was not correlated to the disease background of a strain isolating from pneumonia, 
arthritis, or mastitis, the adherence capability of pathogenic strains of M. bovis was much 
higher than that of non-pathogenic strains ( 46). M. bovis was also capable of attachment to 
bovine alveolar macrophages and neutrophils (55) . Heat treatment of M. bovis at 56 °C for 
30 min reduced but did not totally eliminate adherence to neutrophils ( 42). 
1.4.2 Invasion 
Although mycoplasmas are generally considered surface parasites, some 
mycoplasmas including Mycoplasma penetrans, Mycoplasma pneumoniae, M. genitalium, 
Mycoplasma gallisepticum, and Mycoplasma fermentans have been demonstrated entering 
into nonphagocytic cells (56-61). Compared to extracellular locations, this intracellular 
location is obviously a privileged niche providing the pathogen the ability to circumvent 
antibiotic activity and immune surveillance (19). 
In contrast, M. bovis was generally considered as an extracellular pathogen. This was 
supported by the report that M. bovis was found on the surfaces of, and between bronchiolar 
epithelial cells, but not in intracellular locations (62). Very recently, it was reported that a 
mycoplasma-like organism was found in the cytoplasm of hepatocytes and renal epithelial 
cells (41). Also, M. bovis antigens were reported to be detected in the intracytoplasmic space 
of bronchiolar epithelial cells (6, 21). 
1.4.3 Cytotoxicity 
The clinical effects of M. bovis infections were suggested to arise from the 
combinations of M. bovis cytotoxicity and host immune and inflammatory responses (13). 
Reactive oxygen species as mild toxic by-products of mycoplasma metabolism have been 
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incriminated in damage to host cell membranes (63). For example, M. penetrans causes the 
vacuolization of the HeLa cells due to the accumulation of organic peroxides (64). Although 
very sensitive to reactive oxygen species-caused damage, bovine fetal tracheal epithelial cell 
explants infected with M. bovis did not exhibit ciliostasis or cytotoxicity (62, 65). 
Neurotoxins as well as capsular polysaccharides produced by mycoplasmas were also 
reported to be cytotoxic to host cells (66, 67). A polysaccharide inflammatory toxin has been 
extracted from M. bovis but its cytopathic effects have not been explored except that infusion 
of this polysaccharide toxin into the udders of cows resulted in eosinophilic mastitis (68). 
Some strains of M. bovis were cytotoxic to Vero (green monkey kidney) cells, A-72 canine 
muscle fibroblasts, and bovine lung fibroblasts when tested by a modified colony 
cytoadherence method (69). Interestingly, those strains isolated from abscess-associated 
pneumonia cases are not cytotoxic to bovine lung fibroblast cells while nonabscess-
associated strains have varied cytotoxicity (47). Recently, it was demonstrated that M. bovis 
induces apoptosis of bovine peripheral blood mononuclear cells and this was dependent on 
de novo protein synthesis by M. bovis (70). 
1.4.4 Evasion of host immune systems 
Mycoplasma infections are usually chronic in nature suggesting frequent failure of 
the host immune systems to efficiently eradicate the parasites (19). Molecular mimicry or 
phenotypic plasticity, defined as antigenic epitopes shared by mycoplasmas and host cells or 
change in antigenic makeup expressed by a single mycoplasma genotype in response to 
environmental conditions, respectively, are identified as two major mechanisms that ensure 
mycoplasmas can circumvent host immune systems (19). Molecular mimicry, as reported for 
M. pneumoniae and M. genitalium, has not been shown with M. bovis (71, 72). 
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However, extensive antigenic variation is observed in M. bovis due to the presence of 
a family of antigenically and structurally related lipid-modified variable surface proteins 
designated as Vsps (73). These Vsps spontaneously undergo a high-rate of noncoordinated 
phase variation between ON-OFF expression states and high-frequency size variation (73). 
Several other gene families mediating antigenic variation have also been identified in other 
mycoplasmas, such as the vlp of Mycoplasma hyorhinis, avg in Mycoplasma agalactiae, vsa 
in Mycoplasma pulmonis, vmm in Mycoplasma mycoides subsp mycoides, and vlhA in 
Mycoplasma synoviae (74-78). 
The vsp locus is a 23-kb genomic fragment containing 13 single-copy vsp genes, each 
of which exists as a complete open reading frame with varied orientation (79). Each vsp gene 
contains a conserved 190 bp, non-coding region at the 5' end, encoding for a ribosome 
binding site. The first 75-bp of translated DNA sequence encodes a highly conserved 
lipoprotein signal peptide. About 80 % of each vsp coding region is composed of reiterated 
sequences of different lengths which are usually organized as one to four distinct regions of 
tandem, in-frame blocks (63). 
There are significant interstrain variations among field M. bovis isolates at both DNA 
and protein level demonstrated by Southern hybridization and Western immunoblotting, 
respectively (44, 80). This was presumed to be due to M. bovis undergoing high-frequency 
V sp variation. The rate of antigenic variation in the vsp locus has been estimated to be 10 -2 
to 10-4 per cell per generation, which is considerably higher than normal mutation rates (2, 
81). 
Phase variation involves DNA rearrangements or inversions by a recombinatorial 
mechanism occurring because of the high sequence similarity among vsp genes (81 ). These 
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inversions resulted in the juxtaposition of an active promotor-like sequence to a silent vsp 
gene, which promotes transcription initiation of the recipient gene (37, 79). Size variation in 
V sps is due to presence of tandem repetitive regions in vsp genes. These repetitive sequences 
produce periodic polypeptide structures and there is variation in the number of copies of the 
repetitive unit (82). 
The V sps are among predominant cell surface antigens recognized during early and 
late stages of infection (80). The expression of V sps is subject to immune modulation in vitro 
in the presence of specific antibodies for Vsps. Interestingly, M. bovis may revert to the 
original phenotype with the removal of inducing antibody (83). 
It was reported that M. bovis possesses a second type of surface antigenic variation 
system represented by the surface protein pMB67 (39). Like V sps, pMB67 also undergoes 
phase and size variation and is a predominant antigen recognized during M. bovis infection 
and diseases. However, pMB67 is not lipid modified and does not contain Vsp-like 
repetitive domains (39). 
1.4.5 Modulation of the immune system 
1.4.5.1 M. bovis and monocytes or macrophages 
Like some encapsulated mycoplasmas including Mycoplasma ovipneumoniae, M. 
pulmonis, and Mycoplasma dispar, unencapsulated M. bovis can colonize the surface of 
macrophages without stimulating phagocytosis in the absence of specific antibodies (55, 84). 
M. bovis can also activate bovine alveolar macrophages and stimulate production of tumor 
necrosis factor-a (TNF-a), a potent proinflammatory mediator (85). The mechanisms used 
for macrophage activation have not been clarified. Lipoproteins on the membrane surface 
could be involved in that lipoproteins are predominantly expressed and mycoplasma 
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lipoproteins stimulate monocytes and macrophages and induce the secretion of 
proinflammatory cytokines including TNF-a, interleukin- I (IL-1 ), and interleukin-6 (IL-6) 
(18, 63, 86). Besides induction of cytokine secretion, several other mycoplasma species were 
reported to stimulate macrophage expression of major histocompability complex molecules, 
and release of hydrolytic enzymes (87 , 88). These effects have not been reported for M. 
bovis. 
1.4.5.2 M. bovis and neutrophils 
Some encapsulated mycoplasmas, like M. dispar, possess antiphagocytic activity and 
this was accredited to their capsular polysaccharide (84). Capsular polysaccharide is capable 
of inhibiting complement activation by alternative pathway or of preventing nonspecific 
deposition of immunoglobulin on mycoplasmas (89). It was reported that M. bovis, as a 
unencapsulated mycoplasmas, can also colonize the surface of neutrophils without inducing 
significant phagocytosis (90). Surface adherent M. bovis has also been shown to decrease 
killing of opsonized E. coli by bovine neutrophils in vitro (90). This was thought to occur 
because M. bovis suppresses activation of neutrophils given the fact that M. bovis inhibited 
phorbol myristate acetate stimulated chemiluminescence on bovine neutrophils ( 42). 
1.4.5.3 Suppression of immune cells 
Mycoplasmas have been shown to induce immune suppression by depletion of 
essential L-arginine, exhibiting cytopathic effects on immune cells, or induce transitory 
anergy (63). However, different mechanisms have been involved in suppression of bovine 
lymphocytes infected with M. bovis. It was reported that viable M. bovis was capable of 
suppression of phytohemagglutinin stimulated bovine lymphocyte responses by interrupting 
3H-thymidine incorporation in lymphocytes (91). The supernatants of M. bovis cultures were 
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also shown to suppress lymphocyte blastogenesis (92). Very recently, a lympho-inhibitory 
peptide designed as Mb-LIP has been identified (93). This 26 amino acid peptide is highly 
homologous to the C-terminus of M. bovis surface protein V spL and was demonstrated to 
inhibit mitogen activity of Concanavalin A on bovine lymphocytes as well as on human 
Jurkat cells (93, Dr. Vanden Bush TJ, the University of Iowa, personal communication). It 
has also been reported that M. bovis was capable of inducing bovine lymphocyte apoptosis 
(70). This apoptotic effect of M. bovis was dependent on de novo protein synthesis in this 
organism. In contrast, in an experimental goat model, M. bovis inoculation induces lymphoid 
hyperplasia of the bronchus-associated lymphoid tissue with the activation of CD4+ 
lymphocytes (21). 
2. Endothelial cells in inflammation 
2.1 Endothelial cell structure and functions 
The vascular endothelium is a single layer of highly specialized epitheloid-type cells 
that form a continuous lining (94). It consists of 1 - 6 x 10 13 cells and forming an almost 1kg 
"organ" in an adult human (95). It is now well established that the vascular endothelium 
serves far more than as a simple passive liner functioning only to prevent blood coagulation 
and to separate the vascular space from the tissue (96). Endothelial cells (EC) play a variety 
of vital roles in the regulation of thrombosis and thrombolysis, platelet formation, modulation 
of vascular tone and blood flow, as well as regulation of atherosclerosis and tumor neo-
angiogenesis (97). Vascular endothelium also plays a critical role in regulating inflammatory 
and immunological responses by influencing transmigration of leukocytes, production of 
cytokines and chemokines, and modulation of vascular permeability (95, 97, 98). 
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2.2 Endothelial cell markers and purification 
A variety of EC-specific markers have been identified in studies of vasculogenesis, 
angiogenesis, characterization of endothelial heterogeneity and in identification of EC (99). 
Coagulation Factor VIII is a glycoprotein complex and its major component is a 200 -250 
kDa disulfide-linked structure. It is present mainly in the Weibel-Palade bodies and in the 
cytoplasm and can be detected by indirect immunofluoresence microscopy (100). Factor 
VIII-von Willebrand factor (vWF) plays an essential role in hemostasis and platelet adhesion 
(100). Most cultured mammalian EC, including those of bovine origin, stain positive for 
factor VIII-vWF although its expression decreases with passage (101). 
EC have a scavenger receptor for rapid uptake of acetylated low-density lipoprotein 
(102). Fluorescence-activated cell sorting has been widely used to purify EC based upon the 
uptake of 1, 1 '-dioctadecyl-3, 3, 3', 3 '-tetramethylindo-carbocyanine perchlorate conjugated 
low-density lipoprotein (Di-Ac-LDL) (101). It has been demonstrated that this receptor is 
expressed both in microvascular endothelial cells (MEC) and macrovascular endothelial cells 
(MaEC). Unlike Factor VIII, it was reported that expression of LDL receptor was not 
decreased with cell passage (101). 
CD146, also known as MCAM, MUC18, or S-Endo-1, is a recently identified 113 
kDa adhesion glycoprotein belonging to the immunoglobulin (lg) superfamily (103). It is a 
Ca2+-independent cell adhesion molecule involved in heterophilic cell-cell interaction (104). 
CD146 is recognized as an EC marker and its expression has been demonstrated in EC of all 
vessels including MEC (104, 105). Magnetic bead sorting using anti-CD146 monoclonal 
antibody has been used to purify human EC by positive selection and can also be used to 
purify bovine pulmonary MEC (BPMEC) (105, Lorraine M Sordillo, Pennsylvania State 
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University, personal communication). Other markers such as anti- platelet /endothelial cell 
adhesion molecule- I have also been used to purify EC ( 106). 
2.3 Activation of endothelial cells and inflammatory mediators 
Endothelial activation was referred to by Cooper as "changes that EC undergo as a 
result of cytokine stimulation (TNF-a, IL-1), inflammatory or infectious conditions, 
reperfusion injury, or rejection of allo- or xenograft" (107). Endothelial activation is 
recognized as a hallmark of established inflammatory leukocyte extravasation, by functional 
activation of adhesion molecules of different types, production of inflammatory mediators, 
release of chemoattractants for various leukocyte populations, and induction of 
prothrombotic molecules (108). 
The current model for leukocyte-endothelial adhesion involves four steps, including 
capture or tethering of circulating leukocytes to the activated EC, rolling, firm adhesion, and 
finally transmigration of leukocytes (109). Many receptor-ligand pairs act in a sequential and 
overlapping manner (110). Several receptor-ligand pairs are involved in leukocyte adhesion 
to activated EC, including: P-selectin and P-selectin ligand, E-selectin and E-selectin ligand, 
intercellular adhesion molecule-I (ICAM-1) and B2-integrins such as leukocyte function-
associated antigen-I (LFA-1) and Mac-l(CD1 lb/CD18), vascular cellular adhesion 
molecule-I (VCAM-1) and very late antigen-4 (96, 111). 
2.3.1 Adhesion molecules on endothelial cells 
E-selectin is responsible for regulating early steps of tethering and rolling in the 
adhesion cascade (112). The C-type lectin-binding domain of E-selectin binds to E-selectin 
ligand- I on leukocytes. Expression of E-selectin is generally restricted to activated EC. It is 
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involved in adhesion of neutrophils, monocytes, and a subpopulation of memory T-
lymphocytes (96). Bovine E-selectin has been _reported involved in regulating adhesion of yo+ 
T cells to cultured human and bovine EC (113). E-selectin expression is inducible in cultured 
EC exposed to IL-1, TNF-a, and lipopolysaccharide (LPS) (112). Inhibition of E-selectin 
expression diminishes inflammatory responses in vivo (96). 
ICAM-1 is involved in firm adhesion of leukocytes to vascular endothelial cells 
(114). It is a primary ligand for ~2-integrins, mainly leukocyte function-associated antigen-I 
and Mac-1 expressed on neutrophils and lymphocytes (115). Although expressed 
constitutively on EC, ICAM-1 is induced or upregulated on EC, epithelial cells, lymphocytes, 
and macrophages (116, 117). Surface expression oflCAM-1 on cultured EC is increased by 
stimulation with TNF-a, IL-1, LPS, or interferon-y (IFN-y) (114). Anti-CD18 or anti-ICAM-
1 antibody is able to reduce neutrophil accumulation in the lungs ( 118). 
Like ICAM-1, VCAM-1 is also a member of the immunoglobulin superfamily and is 
involved in firm adhesion (114). It is a ligand for very late antigen-4 on monocytes and 
lymphocytes, however, very late antigen-4 is not expressed by neutrophils (114). 
Eosinophils and basophils can also bind to activated endothelium through VCAM-1 (119, 
120). VCAM-1 can also be induced on the surface of activated small or large vessels by 
stimuli such as TNF-a, IL-1, and LPS (114). Expression ofVCAM-1 correlates with 
increased mononuclear leukocyte infiltrates, consistent with its ability to support the 
adhesion of leukocytes and monocytes but not neutrophils (96). 
2.3.2 Chemokines in endothelial cells 
Chemokines are a family of small 8-14 kDa, soluble polypeptides with chemotactic 
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activity for distinct but overlapping subsets of leukocytes (121). There are more than 50 
chemokines identified and these are classified into four groups including CXC- (a-) and CC-
(~-), CX3C-, and C- subfamilies, based on the presence and position of the first two 
conserved cysteine residues (122). Members of the CXC family predominantly act on 
neutrophils, whereas members of the CC family act on monocytes, eosinophils, and 
basophils, even though there are many exceptions (121). Chemokines bind and signal 
through their seven transmembrane-spanning G-protein-coupled receptors on leukocytes 
(123) . Expression of chemokine receptors varies greatly among different leukocyte types 
(122). Therefore, chemokines, acting in combination with adhesion receptors, play an 
essential role in mediating the recruitment of specific leukocyte populations through 
adhesion triggering and directed migration (122). 
Chemokines act in concert with adhesion molecules on EC to recruit leukocytes to 
inflammatory sites. To mediate firm adhesion, quiescent integrins on circulating leukocytes 
must be activated by increasing integrin affinity through conformational changes or 
increasing integrin avidity by clustering of low-affinity integrins (121, 124 ). Activation of 
leukocyte signals is produced during tethering of resting leukocytes on activated EC by a 
variety of mediators including E-selectin, some nonspecific chemoattractants such as platelet 
activating factor, leukotriene B4, and complement component C5a (121, 125). However, 
chemokines, produced locally by activated EC, are among the most important integrin 
activators (121). 
Interleukin-8 (IL-8) is a potent chemoattractant for neutrophils belonging to the 
CXC-subfamily (126). IL-8 induces the up-regulation of neutrophil ~2-integrins, resulting in 
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attachment of neutrophils to unstimulated EC via Mac-1, induction of respiratory burst, and 
release of neutrophil granules ( 126). IL-8 is secreted by IL-1, TNF-a, or LPS-stimulated EC 
but not by IL-6 (126). 
Both monocyte chemoattractant protein- I (MCP-1) and regulated upon activation 
normal T cell expressed and secreted (RANTES) are potent monocyte-specific chemokines 
belonging to the CC-subfamily (127). They have chemotactic activity for both monocytes 
and lymphocytes in vitro (127). RANTES also has a chemotactic activity for eosinophils 
(128). Induction of MCP-1 by vascular endothelium is regarded as the most important factor 
for the initial recruitment of monocytes to inflamed tissues (129). Both MCP-1 and RANTES 
can also be produced by nonvascular cells, including fibroblasts, macrophages, and 
lymphocytes (130). Expression of MCP-1 and RANTES by EC can be regulated by TNFa, 
IL-1, or LPS (121). 
2.3.3 Proinflammatory cytokines in endothelial cells 
Cytokines are a group of hormone-like short polypeptide mediators acting in an 
autocrine, paracrine, or endocrine fashion by binding to their specific receptors on cells 
( 131 ). Cytokines such as TNF-a, IL-1, and IL-6 are classified as inflammatory cytokines 
because they are involved in inflammatory processes by promoting leukocyte extravasation 
(132). Vascular EC are both a target and a source for proinflammatory cytokines (132). 
IL-1 is a prototypic cytokine with two forms IL-la and IL-1~ binding to the same 
receptor (131). IL-1 is elicited by activated EC stimulated with TNF-a or LPS. IL-1 can also 
be released by apoptotic EC and serve multiple functions such as enhancing endocytosis of 
apoptotic bodies by surrounding endothelial cells, or activating neighboring EC through the 
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activation of nuclear factor kappa B (NF-KB) (133, 134). IL-1 induces production of several 
cytokines in EC, including various chemokines, IL-6, and IL-1 itself ( 135). It also enhances 
procoagulant activity of EC (136). 
IL-6 is another proinflammatory cytokine and production of copious amounts of IL-6 
by EC can be induced by multiple stimuli including IL-1 or TNF-a ( 131, 13 7). IL-6 is 
involved in angiogenesis and vascular tumor formation (132). IL-6, together with soluble IL-
6 receptor induces chemokine production in EC and may play an important role in leukocyte 
migration (132). 
2.4 Killing of endothelial cells 
In addition to activation of EC, under certain conditions, cytokines such as TNF-a, 
IL-1~, IFN-y or their combinations or endotoxin can be toxic to EC (138). Induction of either 
apoptosis or necrosis of EC has been reported by many infectious agents such as bluetongue 
virus, Rickettsia rickettsi, Haemophilus somnus, or Staphylococcus aureus (139, 140). 
2.5 Heterogeneity of macro- and micro-vascular endothelial cells 
Most of our knowledge about EC comes from the study of human umbilical vein EC 
(HUVEC) and bovine aortic EC, two extensively studied MaEC models (99, 101). However, 
it is important to emphasize that EC are a heterogeneous population with species-, organ-, as 
well as vessel size-specificity (101). With improvements of purification and culture ofMEC, 
the existence of significant heterogeneities between macro- and micro-vascular endothelium 
are increasingly recognized. These heterogeneities are expressed in a number of ways 
including phenotypes, expression of adhesion molecules and chemokines in response to 
inflammatory stimulation, and sensitivity to injury by activated neutrophils or other 
20 
mediators. 
2.5.1 Phenotypes 
In regard to phenotypes, sheep lung and brain MEC do not contain Weibel-Palade 
bodies and do not express von Wille brand factor, compared with sheep aortic EC (101 ). It 
was also reported that MEC strongly express ICAM-1 and major histocompability complex 
classes I and II, and these molecules are weakly expressed or undetectable on large vessels, 
which suggested that MEC may be more efficient at antigen presentation or more susceptible 
to immune attack (141 ). Also, studies using two-dimensional gel electrophoresis show a 
number of discrepancies in protein profiles between lysates of cultured bovine pulmonary 
microvascular EC (BPMEC) and bovine pulmonary artery EC (142). 
2.5.2 Responses to stimuli 
Human lung MEC express higher level of ICAM-1 when compared with similarly 
stimulated human AEC (143). Correlated with higher expression of IL-8 receptors such as 
CXCRl and CXCR2, IL-8-stimulated human dermal MEC have more potent chemotactic 
activity than HUVEC (144). However, E-selectin and VCAM-1 were strongly induced in the 
larger vessels of lung tissues from patients that died of acute respiratory distress syndrome, 
while there was only a mosaic-like weak expression in the capillaries (145). Similar VCAM-
1 expression profile was reported on HUVEC and dermal MEC induced with TNF-a and 
IFN-y (146). There is a differential adhesion of human neutrophils to EC after TNF-a 
stimulation under venous flow condition. Adhesion of neutrophils only increased on human 
pulmonary MEC but not on HUVEC (147). Different adhesion molecules might be also 
involved in lymphocytes adherence to LPS-stimulated sheep pulmonary MEC and HUVEC, 
because antibodies known to block adhesion of lymphocytes to HUVEC failed to block this 
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adhesion (148). Compared to rat lung MEC, rat aortic EC stimulated with LPS and cytokines 
express more transcriptional inducible nitric oxide synthase as evidenced by more nitrite and 
nitrate production (143, 149). Similar trends were observed in human lung MEC and human 
aortic EC. 
2.5.3 Sensitivity to injury 
There is differential sensitivity of MaEC and MEC in response to injury mediated by 
phorbol 12-myristate 13-acetate -activated neutrophils (150). For example, rat lung MEC are 
more susceptible than EC derived from larger lung vessels and aorta. In contrast, it has been 
shown that both endotoxin and TNF are cytotoxic only to bovine pulmonary artery but not to 
pulmonary microvasculature (142, 151 ). 
It is highly desirable to compare potential differential responses of bovine aortic EC 
and BPMEC to M. bovis infection since only localized but not systemic vasculitis was 
observed during M. bovis infection (Dr Ricardo F. Rosenbusch, Iowa State University, 
personal communication). 
2.6 Mycoplasmas and endothelial cells 
2.6.1 Cytotoxicity 
Multiple mycoplasmas have been reported to be cytotoxic to EC. Infection of goat 
aorta tissue with M. mycoides subsp. mycoides led to shedding of EC layer with the exposure 
of subendothelial collagen (152). It has been reported that M. mycoides subsp. mycoides 
small colony-type strains are cytotoxic to cultured bovine EC and are less cytotoxic to 
caprine or porcine EC (153). The cytotoxicity is not correlated with their adherence 
capability (154). Capsular galactan purified from M. mycoides subsp. mycoides was 
identified as one of the virulence components of the organism and regarded as a potential 
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factor causing cytotoxicity (67). Intravenous injection of galactan into calves caused 
hemorrhages of vessel walls, pulmonary edema, and capillary thrombosis suggesting 
pathological changes of EC (67). Interestingly, the degree of virulence of a strain was 
correlated with the quantity of galactan produced in culture (155). 
An inflammatory toxin has been extracted from M. bovis (68). This 73 kDa 
polysaccharide toxin is heat-stable, absent of protein and lipid although the holotoxin is a 
glycoprotein (68). The cytotoxic effects of this toxin on its bovine host have not been 
reported. However, it is capable of increasing vascular permeability by intravenous 
inoculation into guinea pigs (68). 
Arginine deiminase (ADI), a 48 kDa protein with the named enzymatic activity, has 
been extracted from Mycoplasma arginini. ADI converts L-arginine, an essential amino acid 
for cell growth, into citrulline. Low concentration of ADI has been demonstrated to have 
anti-angiogenic activity, while high concentration leads to apoptosis of various cultured cells 
by depletion of arginine as well as arresting cell cycle in G (1) and/or S phase (156, 157). 
2.6.2 Vasculitis 
Vasculitis is characterized by inflammation and necrosis of blood vessels (158). 
Infectious agents can directly mediate damage to vessels by multiple pathological 
mechanisms (159). Some mycoplasmas have been reported to cause diseases associated with 
vasculitis. For instances, M. pneumoniae infections in humans can cause 
meningoencephalitis with vasculitis (160, 161). Mycoplasma neurolyticum infection in mice, 
M. gallisepticum in turkeys, and M. mycoides subsp. mycoides SC-type strains in bovine are 
associated with forms of vasculitis (162, 163) . Localized lung vasculitis has been observed 
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in cattle experimentally infected with M. bovis (Dr. Ricardo F. Rosenbusch, Iowa State 
University, personal communication). 
2.6.3 Coagulation disturbance and vasomotor factors 
M. mycoides subsp mycoides SC-type strains can cause bovine coagulation 
disturbance with increased blood fibrinogen, prolonged prothrombin time, and decreased 
platelet count (152). Thrombosis of the subsynovial vessels and aggregates of platelets have 
also been reported in calves inoculated intraarticularly with M. bovis (4, 43). 
Infection of mycoplasmas has been reported to affect certain vasomotor factors. 
Endothelin-1 is a potent vasoconstrictor involved in disordered coagulation and blood 
pressure. It was found that infection of Mycoplasma spp. on cultured HUVEC increases 
endothelin-1 production ( 164 ). Bradykinin is a potent vascular permeability inducer. 
Incubation of bradykinin with some mycoplasmas was found to inactivate the vascular 
permeability-increasing activity of bradykinin (165). 
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CHAPTER 3. DIFFERENTIAL GENE EXPRESSION AND 
CYTOTOXICITY OF BOVINE AORTIC AND PULMONARY 
MICROV ASCULAR ENDOTHELIAL CELLS INFECTED WITH 
MYCOPLASMA BOVIS 
Abstract 
A paper to be submitted to Microbial Pathogenesis 
April, 2004 
Xiaodong Lu, Ricardo F. Rosenbusch 
Mycoplasma bovis is an etiological agent of bovine pneumonia, arthritis, and mastitis. 
Localized vasculitis, perivascular mononuclear cell infiltrations, as well as accumulation of 
inflammatory cells in lung and joint lesions have been reported, highlighting the importance 
of studies of the changes on vascular endothelium infected with M. bovis. The purpose of 
this study was to determine the ability of M. bovis to directly elicit mediators involved in 
inflammatory cell extravasation as well as its cytotoxicity to bovine vascular endothelium. 
We compared differential activation of bovine aortic (BAEC) and pulmonary microvascular 
endothelial cells (BPMEC) as well as differential effects caused by abscess forming strain 
428E and nonabscess-forming strain DSA16. Expression of genes for MCP-1, RANTES, 
ICAM-1, IL-8, IL-1~, and IL-6 in endothelial cell monolayers was determined by SYBR 
Green real-time PCR, and VCAM-1 protein expression was determined by flow cytometry 
analysis at various times postinfection with mycoplasma. In addition, cytotoxicity of M. 
bovis to endothelial cells was determined by propidium iodide uptake and flow cytometry 
analysis. We found that infected BPMEC increased both MCP-1 mRNA and VCAM-1 
surface protein expression, two mediators involved in mononuclear cell transmigration. 
However, ICAM-1, a mediator participating in neutrophil transmigration, was not induced in 
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these cell types. We also found that M. bovis-induced activation differed markedly between 
BAEC and BPMEC, with no induction of MCP-1, IL-8 and a later induction oflL-1 ~ and IL-
6 in BAEC than BPMEC. Although a higher expression of VCAM-1 was generated by strain 
428E infection, we found that strain DSA16 induced a higher rnRNA expression oflL-1~, 
IL-6, MCP-1 and IL-8 in BPMEC. In addition, we demonstrate that only DSA16 is 
subcytotoxic to both cell types. Taken together, these in vitro results correlate well with 
infiltration of mononuclear cells at pulmonary microvascular sites as observed in vivo. 
1. Introduction 
M. bovis is a member of the genus Mycoplasma, and these are the smallest free-living 
and self-replicating microorganisms, which are uniquely characterized by the absence of a 
cell wall and very small genome size [1]. It is known to be an etiological organism 
responsible for pneumonia and arthritis in calves and mastitis in dairy cows [2]. It has also 
been implicated as a cause of otitis media, decubital abscesses, and genital disorders [2-5]. 
While M. bovis is highly adapted to cattle, occasional isolations have been made from 
buffalo, small ruminants and even humans [6]. It is widely spread globally and causes 
significant economic losses annually to the cattle industry [6]. 
Many reports point out that there is a systemic phase of M. bovis disease, including a 
potential interaction of M. bovis with EC. For instance, recognized as one of the most 
invasive bovine pathogens [7], M. bovis was capable of invading through epithelial junctions 
and entering the bloodstream [2, 7, 8]. Systemic dissemination of M. bovis has been 
confirmed by isolation M. bovis from multiple body sites including blood [ 4, 7]. Infection of 
joints and mastitis through hematogenous route has also been reported [1, 9, 10]. Localized 
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lung vasculitis was observed and the presence of thrombi within subsynovial vessels suggest 
an interaction of M. bovis with the vascular endothelial cells [11, 12]. 
EC play a vital role in inflammation and immunity, with upregulation of adhesion 
molecules such as VCAM-1, ICAM-1, and release of immunologically active factors such as 
cytokines and chemokines in response to inflammatory stimuli [14]. Emigration of 
monocytes, neutrophils and lymphocytes was demonstrated in M. bovis infected lung and 
joint lesions, depending on the orchestrated role played by adhesion molecules, chemokines, 
and cytokines induced by activated EC [8, 12] . However, there is considerable 
heterogeneity between vascular EC from different anatomical sites in response to even the 
same stimuli. For example, differential reaction of bovine pulmonary artery EC and BPMEC 
to endotoxin or TNF-a stimulation has been reported [15, 16]. Therefore, the finding of 
significant site-specific differences in EC response to M. bovis infection may have important 
biological and clinical implications. 
In this study, we have used real-time PCR to compare the expression of six genes 
between cultured BAEC and BPMEC infected with M. bovis. These genes include 
chemokines (MCP-1, RANTES, and IL-8), an adhesion molecule (ICAM-1), and 
proinflammatory cytokines (IL-1~, and IL-6). We also used flow cytometry to examine the 
surface expression of VCAM-1 in M. bovis infected EC. Cytotoxicity of M. bovis for bovine 
EC was studied by propidium iodide uptake. However, heterogeneity among M. bovis strains 
has been reported including differences in attachment to host cell as well as abscess-
formation potential [8, 13]. For comparative purpose, a nonabscess-forming strain (DSA16) 
and an abscess-forming strain (428E) of M. bovis were used. The purpose of this study was to 
define differential responses of cultured vascular endothelium to M. bovis infection. 
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2. Results 
2.1 Induction of mediators specific for mononuclear cell transmigration in M. bovis-infected 
endothelial cells 
Like other mycoplasma infections, chronic M. bovis infection of the lung is 
characterized by infiltration of mononuclear cells including monocytes [8]. We tested 
induction of mediators specific for mononuclear cell transmigration, including VCAM-1, 
MCP-1, and RANTES by M. bovis-infected EC. VCAM-1 surface expression increased 
markedly as determined by indirect immunostaining with the use of a cross-reactive 
monoclonal antibody raised against human VCAM-1 (Fig. 1). In each cell type, VCAM-1 
was significantly increased compared to PBS controls at 15 and 24 hr post-of-infection (PI) 
(P < 0.01), with higher expression of VCAM-1 at 24 hr. A similar induction pattern of 
VCAM-1 expression between M. bovis strains DSA16 and 428E was observed in both cell 
types. However, abscess-forming strain 428E induced significantly higher expression of 
VCAM-1 than that of nonabscess-forming strain DSA16 at 15 and 24 hr (P < 0.001). Strain 
428E also induced early expression of VCAM-1 at 6 hr in BPMEC but not in infected 
BAEC. Assessed by real-time PCR, we observed that MCP-1 was only induced in BPMEC 
but not in BAEC (Fig. 2). The difference between DSA 16 and 428E in induction of MCP-1 is 
statistically significant (P < 0.001), with 6.5-fold and 4.5-fold increases at 6 hr, respectively 
(Fig. 3). Similar fold increases were observed at 12 hr. RANTES, however, was not induced 
in any infected cell types at either time points (Fig. 2). 
2.2 Expression of mediators specific for neutrophil migration in M. bovis-infected EC 
Accumulated neutrophils have been demonstrated in the center of foci of M. bovis-
infected lung or joint lesions [8], although it is not a predominant infiltrating cell type in M. 
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Fig. 1 VCAM-1 surface expression is increased in BAEC (A) and BPMEC (B) cultures 
infected with M. bovis. Monolayers of BAEC and BPMEC (5 x 105) were infected with M. 
bovis strain DSA16 and strain 428E at 1000 mycoplasma/cell for 6, 15, or 24 hr. PBS was 
used as a mock-infection. Cells were stained for VCAM-1 followed by FITC-conjugated 
secondary antibody. Ten thousands events in a live cell gate per time point were analyzed 
using FACScan flow cytometry and results were expressed as mean of VCAM-1 positive cell 
percent ± SD for each time point in three separate experiments. Significant differences (P < 
0.05) between each treatment at each time point are indicated with different letters. 
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Fig. 2 Detection of mediator mRNA expression specific for mononuclear cell migration 
(MCP-1 and RANTES) by cultured BAEC and BPMEC infected with M. bovis. Monolayers 
were infected with M. bovis strain DSA16 or strain 428E at 1000 mycoplasmas/cell, 1 µg/ml 
LPS, or PBS. Total RNA was extracted from cell lysates at time points indicated on the x-
axis, samples were reverse transcribed by random primers and used as template for MCP-1, 
or RANTES transcripts in real-time PCR. Results were normalized to G3PDH and relative to 
PBS and expressed as n-fold differences to PBS-treated each cell type at each time point, 
respectively. Significant differences (P<0.05) among each treatment were analyzed by two-
way ANOV A followed by LSD test and were indicated with different letters. 
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Fig. 3 Detection of mediator mRNA expression specific for neutrophil migration (ICAM-1 
and IL-8) by cultured BAEC and BPMEC infected with M. bovis. The same method was 
described in Fig 2 except real-time primers specific for bovine ICAM-1 and IL-8 were used. 
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bovis infection. We analysed transcriptional expression ofICAM-1 and IL-8, two mediators 
mainly involved in neutrophil transmigration. Unexpectedly, we found that ICAM-1 was not 
induced in any type of cells by M. bovis infection (Fig. 3). IL-8 was only induced by infected 
BPMEC but not by BAEC at either time point (Fig. 3). Compared to strain 428E, we found 
that DSA16 induced a higher expression of IL-8 (P < 0.001). Expression of ICAM-1 and IL-
8 was increased by stimulation with LPS in both cell types (data not shown). 
2.3 Expression of inflammatory cytokines in M. bovis-infected EC 
Because proinflammatory cytokines have been reported to play an important role in 
regulating adhesion properties or permeability of producer EC or nearby EC [17], we 
measured gene expression of IL-1 ~ and IL-6 in infected EC. Signals for both IL-1 ~ and IL-6 
mRNA were significantly increased (P < 0.05) in infected BPMEC at both 6 and 12 hr of PI 
(Fig. 4). However, these induced expressions were only observed at 12 hr in BAEC. Also, 
strain DSA16 induced significantly higher expression ofIL-1~ and IL-6 than 428E in 
BPMEC, while the strain differential effect was not seen in BAEC (Fig. 4). 
2.4 Treatment of BAEC and BPMEC with M. bovis alters cell viability 
Uptake of propidium iodide was used to determine whether M. bovis is cytotoxic 
to BAEC and BPMEC after a 24 hr incubation period. Compared to noninfected cells, only 
about 1 % and 3 % of BAEC and BPMEC were killed by M. bovis, respectively (Fig. 5). It 
was found that BPMEC had a higher base line of propidium iodide-positive stained cells. We 
also found that only strain DSA16 is subcytotoxic to both EC types but not 428E. 
3. Discussion and conclusions 
Recognized as a highly invasive bovine pathogen, M. bovis has been reported to 
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Fig. 4 Detection of inflammatory mediator specific mRNA expression (IL-1~ and IL-6) by 
cultured BAEC and BPMEC infected with M. bovis. Same method was described in Fig 2 
except real-time PCR primers specific for bovine IL-1~ and IL-6 were used. 
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Fig. 5 M. bovis DSA16 is subcytotoxic to BAEC (A) and BPMEC (B). Monolayers (5 x 105 
cell) were infected with M. bovis at 1,000 mycoplasma/cell for 24 hr, cells were stained with 
propidium iodide (10 µg/ml) and analysed by flow cytometry as described in Section 4. 
Statistical analysis was done by two-way ANOV A followed by LSD test (P < 0.05). 
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penetrate through the lung epithelial junctions and cause systemic infections such as arthritis 
and mastitis following pneumonia. Localized vascular changes in M. bovis infections have 
been suggested with observed perivascular infiltration of mononuclear cells in lung and joint 
lesions, thrombosis, and localized vasculitis. In this study, primary bovine EC cultures were 
used as an experimental model for studying the patho-physiological changes caused by M . 
bovis infection. It has been reported that in vitro observations using EC are well correlated to 
in vivo reactions associated with the modulation of cytokine and adhesion molecule 
production [18, 19]. 
Both VCAM-1 and ICAM-1 are members of the immunoglobulin superfamily. 
VCAM-1 binds to very late antigen-4 on macrophages or lymphocytes while ICAM-1 binds 
to leukocyte function-associated antigen-1 or Mac-1 on neutrophils [20]. MCP-1 and 
RANTES belong to the CC chemokine W-chemokine) subfamily and have preferential 
chemotactic activity for monocytes and lymphocytes, which are predominant cells in chronic 
inflammation induced by mycoplasmas [21, 22]. However, IL-8 belongs to the CXC 
chemokines (a-chemokine) subfamily and has potent neutrophil attractant properties [21]. 
Recruitment of neutrophils and macrophages to the inflammatory sites is tightly regulated by 
adhesion molecules on activated EC and chemokines [23]. 
In the present work, mediators specific for macrophage/monocyte transmigration such 
as VCAM-1 (Fig. 1) and MCP-1 (Fig. 2) were induced in M. bovis-infected BPMEC. 
However, ICAM-1, which is specific for neutrophil but not for macrophage migration was 
not induced in any type of EC (Fig. 3). Thus, these in vitro data are consistent with the 
observed perivascular infiltration of predominantly macrophages and lymphocytes in M. 
bovis-infected calves. Differential stimulation of VCAM-1 and ICAM-1 expression has been 
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reported, suggesting different signaling pathways for VCAM-1 and ICAM-1 expression [24, 
25]. 
Here, we report that M. bovis infection of primary EC triggers MCP-1 mRNA 
expression but not RANTES. This was similar to the observation that increased MCP-1 
mRNA and protein but not RANTES was found in the lung of Mycoplasma pulmonis-
infected mice [22]. Increased MCP-1 expression has been reported in a variety of cells 
infected with mycoplasmas or their components, including lung epithelial cells, monocytes, 
synoviocytes, and bronchoalveolar lavage cells [26-29]. Studies have demonstrated that 
RANTES was not increased in some Mycoplasma pneumoniae-infected nasal and human 
bronchial epithelial cells, although it was expressed in infected human small airway epithelial 
cells [30, 31]. Differential regulation of RANTES and MCP-1 expression has also been 
reported [28]. Interestingly, MCP-1 was not induced by infected BAEC. Similarly, it was 
observed that MCP-1 was only induced in human brain microvascular EC but not by 
HUVEC infected with Streptococcus suis serotype 2 [17]. 
We also observed increased expression of genes encoding inflammatory cytokines 
such as IL-1~ and IL-6 by M. bovis-infected EC (Fig. 3). Increased IL-1~ may mediate gene 
expression of cytokines, chemokines, and adhesion molecules by autocrine or paracrine 
interaction [32]. Also, it is very likely that macrophage derived mediators also regulate the 
activation of EC in M. bovis infected bovine. Induction of TNF-a has been reported by 
bovine alveolar macrophages infected with M. bovis, and TNF-a is a potent stimulator 
capable of inducing ICAM-1 and VCAM-1 expression on BAEC as well as some other 
mediators by activating NF-KB [20, 33, 34]. These proinflammatory cytokines may also play 
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an important role in initiating localized changes in permeability or adhesion properties of EC 
[17]. 
Interestingly, we found that BPMEC are more sensitive to M. bovis induced 
activation than BAEC, with the induction of MCP-1, IL-8, earlier VCAM-1 and induction of 
cytokines. Similar tendency was also observed in human brain microvascular EC and 
HUVEC infected with Streptococcus suis [ 17]. Production ofIL-6, IL-8, and MCP-1 was 
only observed by S. suis stimulated human brain microvascular EC but not HUVEC. One 
potential possible explanation is that there are differential receptor expressions on BPMEC 
and BAEC. There are a number of discrepancies in proteins between lysates of BPMEC and 
bovine pulmonary artery EC, and some receptors have only been demonstrated in 
microvascular cells [15, 35, 36] . 
In addition to differential activation responses to pathogens, differential cytotoxicity 
of micro- and macro-vascular EC was also observed between BPMEC and bovine pulmonary 
artery EC treated with endotoxin or TNF-a [15, 16]. Cell lysis or increased release of lactate 
dehydrogenase was only demonstrated in endotoxin or TNF-a treated pulmonary artery EC 
but not BPMEC. However, rat pulmonary microvascular EC was more susceptible to injury 
caused by phorbol ester-activated neutrophils than rat pulmonary artery EC [14]. A very 
small percent of BAEC and BPMEC were killed by M. bovis infection, as assessed by 
propidium iodide uptake (Fig. 5). It has been reported that encapsulated mycoplasmas such 
as M. mycoides sub. mycoides are cytotoxic to host EC [37 , 38]. Also, the galactan capsule 
extracted from M. mycoides subsp. mycoides has been demonstrated to be cytotoxic [39, 40]. 
Recognized as a unencapsulated mycoplasma, a 73 kDa inflammatory polysaccharide toxin 
has been extracted from M. bovis, but no direct cytotoxicity of this toxin on bovine cells was 
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observed [41]. Thus, both early activation and later killing of EC were observed by M. bovis 
infection. This phenomenon has also been reported for EC. Activation and apoptosis were 
reported in BPMEC infected with Bluetongue virus, and HUVEC infected with 
Staphylococcus aureus [42-45]. Activation and cytotoxicity of BAEC were also reported 
after stimulation with LPS and TNF-a [46, 47]. 
Significant differential effects on EC between strain DSA16 and 428E were observed 
in this study especially in microvascular EC, including expression of VCAM-1, induction of 
MCP-1, IL-1, IL-6, and propidium iodide uptake. Differential cytotoxic effects of these two 
strains on bovine lung fibroblast cells were observed in our lab, with only strain DSA16 
being cytotoxic (Rosenbusch RF, nonpublished data). This is consistent with the present 
observation that only strain DSA16 is cytotoxic to endothelial cells as demonstrated by 
propidium iodide uptake assay. Abscess-forming strains of M. bovis, such as 428E do give 
lesions with accumulation of transmigrated neutrophils [8]. We show here that this neutrophil 
transmigration is in response to signals other than those produced by EC. The nature of such 
signals remains undetermined. 
Here, we report that M. bovis infection differentially activates BAEC and BPMEC, 
with the upregulation of cytokines, chemokines, and adhesion molecules. We have shown 
that activation of EC result in the induction of mediators or adhesion molecules that are 
specific for mononuclear cell translocation at the microvascular level. We also demonstrated 
that a small percent of EC were killed by M. bovis DSA16 infection. Taken together, our 
findings have potential implications for explaining the observed perivascular infiltration of 
mononuclear cells and localized vasculitis observed in the lung. 
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4. Materials and methods 
4.1 Isolation and culture of EC 
Primary EC cultures were derived from the aorta and pulmonary microvasculature of 
newborn healthy, mycoplasma-free and bovine diarrhea virus-negative calves. The aorta and 
lungs of calves were obtained immediately following euthanasia and were transported on ice 
in Hanks' balanced salts solution that contained penicillin, streptomycin, and fungizone. 
BAEC were isolated using a standard scraping technique and cultured as described 
previously [48, 49]. BPMEC were isolated as previously described [50]. Second passage 
BPMEC were reacted with mouse anti-human IgG 1 CD146 (Chemicon International, 
Temecula, CA) and magnetically sorted using rat anti-mouse IgG1- coated magnetic beads 
(Miltenyi, Auburn, CA) following the manufacturer's recommendations [51, 52] . Sorted 
BPMEC were maintained in Dulbeco's modified Eagle's medium (Sigma, St. Louis, MO), 
supplemented with 10 ng/ml microvascular endothelial cell growth factor (Cascade 
Biologics, Portland, OR), 1 µg/ml hydrocortisone, 10 % heat-inactivated fetal calf serum 
(tested BVDV-negative by PCR), 50 µg/ml gentamycin, 50 ng/ml amphotericin B, and 10 
µg/ml heparin. All EC were cultured on gelatin-coated plastic surfaces as reported elsewhere 
[53]. Cultures of BAEC and BPMEC were identified by their immunoreactivity against 
Factor VIII-associated antigen (Sigma, St. Louis, MO), positive uptake of 1,1' -dioctadecyl-3, 
3, 3', 3 '-tetramethylindocarbocyanine perchlorate conjugated to acetylated low-density 
lipoprotein (Biomedical Technologies, Stoughton, MA) and mouse anti-human IgG1 CD146 
staining [43]. Confluent cells were passed by detachment using trypsin/ EDTA and BAEC 
from passage 6 to 8 and BPMEC from passage 9 to 12 were used in all experiments. Cell 
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purity for sorted BPMEC and nonsorted BAEC was about 90-95 % by CD146 staining and 
nearly 100 % by Di-Ac-LDL uptake. 
4.2 Preparation of M. bovis 
M. bovis strains DSA16 and 428E were isolated from clinic cases and preparation of 
M. bovis was described previously and done with modifications [54]. Briefly, stock cultures 
were grown in modified Friis broth at 37 °C, 2.5 % CO2• M. bovis was harvested by 
centrifugation (18,000 x g for 20 min at 4 °C, washed three times in PBS pH 7.4, passed 
through 25 G needle twice, and frozen in 100 µl aliquots at -70 °C until needed. Aliqouts 
were titrated by counting colony-forming units (CFU) on Friis agar plates [13]. 
4.3 Exposure of EC to mycoplasma or LPS 
BAEC or BPMEC were seeded at 5 x 104/ml density either in gelatin-coated 24-well 
plates (for VCAM-1 staining and PI staining) or 25-cm2 flasks (for total RNA isolation) and 
grown for 2 or 3 days at 37°C, 5% CO2,respectively. Growth medium was discarded and 
DMEM supplemented with 2 % fetal calf serum was added. EC were exposed to M. bovis 
strain DSA16 or 428 Eat 1,000 mycoplasmas per EC, or 1 µg/ml of LPS (Escherichia coli 
O55:B5, Sigma Chemical Co., St. Louis, MO). Infected BAEC and BPMEC were subjected 
to VCAM-1 surface expression analysis at 6, 15, or 24 hrs PI, RNA isolation at 6 or 12 hr of 
PI, or uptake of propidium iodide analysis at 24 hr Pl. As negative controls, cells were 
inoculated with PBS as mock infection. 
4.4 Surface expression of VCAM-1 
Flow cytometric analysis was performed essentially as previously described [20] . 
Briefly, cells from two wells (24-well plates) of plates were trypsinized, washed and 
resuspended in PBS (1 x 106/ml). Cells were incubated at 4 °C with mouse anti-human IgG, 
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VCAM-1 (clone Hae2a, a gift from Dr. T Tedder at Duke University) for 30 min, washed 
with PBS, and labeled for 30 min at 4 °C with FITC-conjugated goat anti-mouse IgG, 
(Southern Biotechnology Association Inc, Birmingham, AL). Samples were fixed with 2% 
paraformaldehyde and kept at 4 °C until analyzed. Isotype control included a mouse IgG1 
(Southern Biotechnology Association Inc, Birmingham, AL) instead of primary antibody. 
Positive control was BAEC or BPMEC infected with 1 µg/ml LPS (E.coli O55:B5, Sigma, 
St. Louis, MO) at 6 hr PI. Data were acquired with a F ACScan flow cytometer (Becton-
Dickinson, Franklin Lakes, NJ) and analyzed with CellQuest software (Becton-Dickinson). 
Results represent mean ± SD of three different experiments, each performed in triplicate. 
4.5 Propidium iodide viability assay 
After the incubation period, detached cells were collected and pooled together with 
trypsinized adherent cells, cells were washed twice in PBS with 1 % bovine serum albumin, 
resuspended in PBS (1 x 106/ml) and stained with 20 µg/ml propidium iodide (Sigma) in the 
dark at room temperature for 10 min [55, 56]. Samples were assayed for viability by 
FACScan analysis (Becton-Dickinson). Results represent mean± SD of three different 
experiments, each performed in triplicate. 
4.6 Isolation of RNA and cDNA preparation 
Infected or noninfected BAEC or BPMEC cultures (about 1 x 106 cells) were lysed 
and total RNA was extracted according to the manufacturer's recommendations 
(RNAqueous-4PCR kit, Ambion, Austin, TX). Contaminating genomic DNA was removed 
by treatment with RNase-free DNase I (DNA-free, Ambion) followed by removing of DNase 
I with DNase inactivation reagent. Each RNA sample was confirmed to be DNA-free by 
PCR targeting the bovine glycerol-3-phosphate dehydrogenase (G3PDH) gene in the absence 
56 
of reverse transcription [57] . The yield of total RNA was measured by using a 
spectrophotometer (Spectronic 601 , Milton Roy Company, Rochester, NY). The cDNA 
synthesis was carried out in a standard reverse transcription reaction using SuperScript II 
RNase ff reverse transcriptase (lnvitrogen, Carlsbad, CA) and Oligo (dT) 15 (Promega, 
Madison, WI) as a primer. The cDNA reaction mixture was diluted 1: 6 using DNase, 
RNase-free distilled water and stored at -20 °C until use. 
4.7 Quantification of mediators by SYBR Green real-time PCR 
Relative mRNA level for each mediator was assessed by quantitating cDNA using a 
SYBR Green real-time PCR assay [57]. Primers IL-1~, IL-6, IL-8, and ICAM-1 used for 
these analyses were from published articles [20, 42, 58]. The following primers: MCP-1 
(L32659), 5'- CAACAGCTTCCACGCTGAAAC-3' and 5'- GTCTGCACATAACTCCT 
TGCC-3 ', RANTES (NM175827) , 5' - CTGCCACTGCCTTCGCTGTC-3' and 5'- CATG 
GAGCACTTGCTGCTGGT-3', and G3PDH (AJ000039), 5' -TTCAACGGCACAGT 
CTGT-3' and 5' -TACTCAGCACCAGCATCA-3', were designed by us using publicly 
available sequence data and Oligo 4.0S software (National Biosciences, Plymouth, MN). All 
primers were tested by running a virtual real-time PCR followed by size analysis for 
expected products. 
The SYBR Green real-time PCR was performed essentially as previously described 
[59] . Briefly, the PCR reactions of 25 µl of 2 x SYBR Green Master Mix (PE Biosystem), 
0.3 µM each of forward and reverse primers, and 5 µl of the 1 : 6 diluted cDNA sample were 
mixed in a final volume of 50 µl. The samples were placed in a 96-well plate (PE 
Biosystems, Foster city, CA) and amplified in an automated fluorometer (ABI Prism 5700 
Sequence Detection System, Applied Biosystems, Foster city, CA). The thermal profile used 
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was 50 °C 2 min, 95 °C 10 min followed by 40 cycles of 95 °C 15s and 60 °C 1 min. The 
specificity of these reactions was confirmed by the dissociation curve as described (Medici, 
DD 2003 App Envir Microbial [60]. Final quantitation was calculated by using the 
comparative CT method as described previously [58, 61]. All data were normalized to levels 
of G3PDH as described, and reported as relative transcription of then-fold difference relative 
to a calibrator cDNA. For each time point, BAEC or BPMEC treated with PBS served as 
calibrators, respectively. Results represent mean± SD of two independent experiments, each 
performed in duplicate. 
4.8 Statistical analysis 
Results were expressed as mean± SD. A two-way ANOV A analysis was carried out 
on cell types and treatments followed by least significant difference (LSD) test for 
comparisons among means. 
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CHAPTER 4. GENERAL CONCLUSIONS 
Summary 
Following entry of the organism into the upper respiratory tract of cattle, M. bovis can 
easily penetrate through lung epithelial cell junctions and enter into blood stream, spread 
hematogenously, and cause systemic infections such as mastitis and arthritis. In the present 
study, effects of M. bovis on bovine endothelial cells were studied. We found that M. bovis 
differentially activated bovine endothelial cells with the induction of mediators specific for 
mononuclear cell extravasation. This is consistent with the observed perivascular infiltration 
of inflammatory cells predominantly of mononuclear type at microvascular level. Although 
not completely correlated with clinical observations, differential effects of M. bovis strains on 
endothelial cells were also observed. Nonabscess-forming strain M. bovis induced higher 
levels of inflammatory mediators and was the only cytotoxic strain to both endothelial cell 
types. 
Recommendations for future directions 
With the discovery of induction of mediators specific for mononuclear cell 
extravasation by M. bovis-infected microvascular endothelial cells, several research 
approaches can be proposed. One is studying monocyte transmigration across bovine 
microvascular endothelial cell monolayers infected with M. bovis. Another is using an in 
vivo model. Microvascular endothelial cells of lung or joint tissues from calves challenged 
with M. bovis can be isolated by laser capture microdissection, followed by RNA isolation 
and real-time PCR to analyse mediators specific for mononuclear cells. Given the observed 
64 
vaccine-induced susceptibility, blocking of mononuclear cell extravasation by anti-VCAM-1 
or anti-VLA-4 should be tested. 
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